Does epigallocatechin-3-gallate inhibit proliferation and migration of human colon cancer SW620 cells in vitro?
EGCG blocks the proliferation and migration of SW620 cells induced by PAR2-AP and factor VIIa via inhibition of the ERK1/2 and NF-κB pathways. The compound may serve as a preventive and therapeutic agent for colon cancers.
These are good protocols, in that overall they satisfy a large part of the proposed criteria, despite the fact that these are demanding criteria. However they can and must improve.